NATAMYCIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for natamycin and what is the scope of patent protection?
Natamycin
is the generic ingredient in one branded drug marketed by Harrow Eye and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for natamycin. Two suppliers are listed for this compound.
Summary for NATAMYCIN
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Clinical Trials: | 7 |
What excipients (inactive ingredients) are in NATAMYCIN? | NATAMYCIN excipients list |
DailyMed Link: | NATAMYCIN at DailyMed |
Recent Clinical Trials for NATAMYCIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stanford University | Phase 3 |
Aravind Eye Care System | Phase 3 |
Thomas M. Lietman | Phase 3 |
Pharmacology for NATAMYCIN
Drug Class | Polyene Antimicrobial |
Medical Subject Heading (MeSH) Categories for NATAMYCIN
Anatomical Therapeutic Chemical (ATC) Classes for NATAMYCIN
US Patents and Regulatory Information for NATAMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | NATACYN | natamycin | SUSPENSION;OPHTHALMIC | 050514-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.